Regulatory actions for July 8, 2026

Source Summary

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.